Contact Information
Company Information
Annual Revenue
75000000.0
Total Funding
215529054.0
Technologies
Outlook
Vimeo
Google Tag Manager
Apache
Google Font API
Google Analytics
Mobile Friendly
WordPress.org
IoT
AI
Keywords
targeted therapy
drug development
antibody drug conjugates & targeted therapy
antibody drug conjugates
biotechnology
biotechnology research
adcs
bioconjugation
oncology treatments
targeted therapeutics
pipelines
pharmaceutical innovation
clinical trials
immunotherapy
cancer indications
payload delivery
linker technology
cysteine-selective conjugation
therapeutic window
biophysical properties
stability
cancer research
investigational drugs
target biology
clinical pharmacokinetics
patient benefit
biotech innovations
phase i studies
fast track designation
solid tumors
patient safety
unique conjugation technologies
drug-to-antibody ratio
therapeutic potential
clinical efficacy
preclinical models
drug stability
treatment outcomes
solid tumor targets
chemistry
phase ii trials
biotechnology partnerships
customizable adcs
research team
platform technologies
drug candidates
drug discovery
neoadjuvant therapy
cancer treatment options
multidisciplinary team
clinical efficacy study
in-vivo potency
pharmaceutical collaborations
health care
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans